Compare CVS Health Corp (CVS) vs State Street SPDR Bloomberg Shrt Trm Hg Yld Bd ETF (SJNK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs State Street SPDR Bloomberg Shrt Trm Hg Yld Bd ETF — how do they compare? CVS Health Corp trades at $94.44 (market cap $119.58B), while State Street SPDR Bloomberg Shrt Trm Hg Yld Bd ETF trades at $24.88. The key difference: CVS Health Corp pays a 2.84% dividend while State Street SPDR Bloomberg Shrt Trm Hg Yld Bd ETF pays none, and CVS Health Corp is trading nearer its 52-week high, State Street SPDR Bloomberg Shrt Trm Hg Yld Bd ETF nearer its low. Which is the better fit depends on your goals.
| CVS | SJNK | |
|---|---|---|
Market Cap | $119.58B | — |
Sector | Health | Sector/Thematic |
52-Week High | $110.60 | $25.63 |
52-Week Low | $65.51 | $24.75 |
Enterprise Value | $181.93B | — |
Dividend Yield | 2.84% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $94.12, down 1.62% today, but maintains strong analyst support with 33 buy ratings and a $115.90 consensus price target. The company delivered three consecutive earnings beats in 2026, with Q2 EPS of $2.58 beating expectations by 38%. Technical indicators show mixed signals with bullish oscillators but bearish moving averages, while fundamentals reveal solid revenue growth to $402.07B in 2025 despite margin compression.
CVS presents a compelling value opportunity with attractive valuation ratios (P/S: 0.29, P/B: 1.5) and strong institutional confidence. Near-term catalysts include continued Aetna recovery and healthcare services expansion, though risks include 2027 PBM pressures and margin volatility. The stock offers 23% upside to analyst targets with defensive healthcare positioning.
SJNK trades at $24.87, up 0.16% on the day, with a bearish technical signal driven by moving averages. Recent news highlights institutional selling, including Cetera Investment Advisers reducing its stake by 9.4% as of July 28, 2026. The ETF maintains regular dividend distributions, with the latest payment scheduled for August 6, 2026.
The outlook is cautious due to technical weakness and negative sentiment from analysts, who cite exhausted tailwinds in high-yield bonds. Risks include interest rate sensitivity and credit spread volatility. Investors should weigh the steady income against potential capital depreciation in a rising rate environment.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About State Street SPDR Bloomberg Shrt Trm Hg Yld Bd ETF
SJNK invests in U.S. dollar-denominated high-yield corporate bonds with short-term maturities (under five years). It offers higher yields than investment-grade funds but with less interest rate sensitivity than longer-term junk bond ETFs.
Read more on SJNK →
